Substance Withdrawal Syndrome Clinical Trial
Official title:
Electro-acupuncture for Protracted Amphetamine Abstinence Syndrome : A Pragmatic Randomized Controlled Trial
In 2019, around 27 million people worldwide, corresponding to 0.5% of the adult population, have used amphetamine-type stimulants (ATS). More than one-third of these 27 million users of ATS were in East and South-East Asia. ATS are a group of synthetic psychostimulants including methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and related substances. Although the biology underlying amphetamine withdrawal syndrome is not fully understood, amphetamine has been shown to produce long-lasting reductions in neuronal expression of dopamine neuronal markers. Abuse of these synthetic psychostimulants can lead to drug addiction, and subsequent withdrawal can cause a series of mental symptoms, such as anxiety, depression, confusion, insomnia, mood disturbances, cognitive impairments, and delusions. Some studies have shown two clear stages of ATS withdrawal syndrome: an acute phase lasting 7-10 days, and a subacute phase lasting a further 2 weeks or more, which is termed called "Protracted amphetamine abstinence syndrome (PAAS)". The relevant literature has indicated that the majority of patients with ATS withdrawal disorders can experience depression, cognitive impairments, insomnia, and anxiety, especially during the PAAS stage. These symptoms may affect the treatment and finally lead to a relapse. Nowadays, pharmacological therapies are mostly symptom-targeted and show an ungratified effectiveness for amphetamine-type drugs. There is no a medication approved by Food and Drug Administration for use in the treatment of methamphetamine addiction. Therefore, the treatment of PAAS is essential for the treatment of ATS use disorders. Traditional Chinese medicine (TCM), especially acupuncture, is effective in the treatment of withdrawal symptoms with few side effects. research on acupuncture detoxification originates from the treatment of opioid drug withdrawal. Studies have shown that acupuncture has high efficacy in the treatment of protracted abstinence symptoms after heroin addiction. This study hypothesizes that acupuncture has the same mechanism of action in the treatment of PAAS as in the treatment of protracted opioid abstinence syndrome. Therefore, investigators have designed a real-world-based pragmatic randomized controlled trial (pRCT) to determine the effectiveness of acupuncture in the treatment of PAAS and provide support for clinical decision-making. Investigators conduct a pragmatic randomized controlled trials(pRCT) to observe the effect of acupuncture in a larger sample. It combines the advantages of randomization and real-world data, and the results can provide the best real-world evidence for the assessment of intervention effects or comparative effects.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00114439 -
Lithium Cannabis Withdrawal Study
|
Phase 2 | |
| Completed |
NCT00980044 -
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
|
Phase 2/Phase 3 | |
| Completed |
NCT02643355 -
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
|
N/A | |
| Completed |
NCT02782156 -
Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENT
|
N/A | |
| Recruiting |
NCT00792415 -
Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool
|
N/A | |
| Completed |
NCT02431728 -
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
|
Phase 1/Phase 2 | |
| Completed |
NCT00695864 -
Effect of Ondansetron for Withdrawal Symptoms
|
N/A | |
| Active, not recruiting |
NCT02951793 -
Abuse and Addiction in ICU
|
||
| Completed |
NCT02108626 -
Electronic Cigarettes in Daily Dependent Smokers
|
Phase 4 | |
| Completed |
NCT02801357 -
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
|
Phase 1 | |
| Completed |
NCT01362959 -
Nicotine Replacement Therapy in the Intensive Care Unit
|
Phase 4 | |
| Completed |
NCT00992979 -
Therapeutic Massage to Manage Withdrawal Related Anxiety
|
Phase 2 | |
| Completed |
NCT02825459 -
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
|
N/A | |
| Completed |
NCT00900900 -
The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers
|
Phase 2 | |
| Completed |
NCT02318290 -
Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study
|
N/A | |
| Completed |
NCT00032968 -
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
|
Phase 3 | |
| Completed |
NCT03374722 -
Opioid Withdrawal Symptoms in Critically Ill Patients
|
||
| Completed |
NCT03435614 -
Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults
|
||
| Completed |
NCT00570219 -
The Effect of Valproate on Benzodiazepine Withdrawal Severity
|
N/A | |
| Completed |
NCT00367874 -
Treatment of Polydrug-Using Opiate Dependents During Withdrawal
|
Phase 4 |